Caris Diagnostics™ (a division Caris Life Sciences™), a leading
provider of integrated anatomic pathology and molecular testing services,
today announced that it has hired 22 subspecialist pathologists in the
areas of Dermatopathology, GI pathology, Hematology/Oncology, Oncologic pathology/tumor
profiling, and Urologic pathology, bringing the total number of Caris
Diagnostics’ expert pathologists to 61.
“We are indeed honored to have such distinguished academic leaders
choose to join our team,” commented Richard H. Lash, M.D., Chief
Medical Officer of Caris Diagnostics. “Their contribution to our
ongoing diagnostic, educational, and research activities will ensure that
Caris Diagnostics secures its position as the premier diagnostics company.”
With the addition of these new pathologists, 36 Caris pathologists hold
or have held academic professorships at the nation’s leading medical
centers, and 9 have both M.D. and Ph.D. degrees. Also in keeping with
our mission of academic-caliber pathology, the pathologists at Caris Dx
have an extraordinary career record of academic productivity including
over 1,500 peer-reviewed publications, 900 abstracts, and 100 books and
The following are among the experts who have recently signed with Caris:
Salima Haque, M.D. has over 17 years of experience in GI and liver pathology.
She completed her fellowship in gastrointestinal, liver and transplantation
pathology at Yale University School of Medicine, then, after 2 more years
at Yale, served as Professor of Pathology and Head of Gastrointestinal
and Liver Pathology at Tulane University. Dr. Haque has published numerous
articles in peer reviewed journals and lectures nationally. Dr. Haque
joins our distinguished GI pathology faculty in Dallas.
Mark Redston, M.D., has over 15 years of GI pathology experience and has
served as Associate Professor, Department of Pathology at Harvard Medical
School and Full Member, Graduate Faculty at the University of Toronto.
He received his GI subspecialty training at Johns Hopkins Hospital and
University and has authored over 90 research publications and book chapters.
Dr. Redston will join us from Ameripath where he served as Managing Director
of GI Diagnostics and Director of Molecular Diagnostics. Dr. Redston will
serve as Medical Director of GI Molecular Pathology for Caris.
Michael Miller, D.O. is a former Professor of Pathology at the University
of Texas Southwestern Medical Center. He completed his Hematology/Oncology
fellowship at the Cleveland Clinic Foundation, where he later served as
Head, Section of Hematopathology and Director, Bone Marrow Transplant
Laboratory. He recently served as Director, Immunohistochemistry, Image
Analysis, and FISH Laboratories for UniPath. Dr. Miller will serve as
Medical co-Director of Hematopathology at our Phoenix laboratory.
Rajal B. Shah, M.D., joins Caris from the University of Michigan where
he served as Clinical Associate Professor of both Pathology and Urology
as well as Director of the Urologic Pathology Section and Urologic Pathology
Fellowship program. He undertook his fellowships in both genitourinary
and surgical pathology from the University of Michigan. Dr. Shah has over
86 peer-reviewed journal publications and book chapters, speaks frequently
at both national and international venues, and has been funded by several
NIH grants. Dr. Shah will direct our new Genitourinary Pathology service
beginning in January.
Raheela Ashfaq, M.D. joins Caris Dx from her position at the University
of Texas Southwestern Medical Center as the Charles T. Ashworth Professor
of Pathology, Professor of Obstetrics and Gynecology, and Director of
OncoDiagnostics tumor profiling laboratory. She has more than 150 peer-reviewed
publications and lectures frequently at national and international conferences.
Leveraging her 10 years of experience in image analysis and tumor profiling
by IHC, FISH, and molecular techniques, Dr. Ashfaq will serve as the Medical
Director of Oncologic Pathology for Caris.
Jill Allbritton, M.D. was previously Assistant Professor of Dermatology
at Johns Hopkins University where she also completed her dermatology residency
and fellowships in dermatopathology and dermatoimmunology. Her areas of
interests include inflammatory disorders of the vulva and medical education
in dermatopathology and clinical dermatology.
Diane Hoss, M.D. joins us from the University of Connecticut Health Center,
where she served as Associate Professor of Dermatology and Director of
the Hair Loss and Scalp Disorders Clinic. Dr. Hoss completed her dermatology
residency at the Dartmouth-Hitchcock Medical Center followed by a dermatopathology
fellowship at Cornell University Medical Center. Her areas of interest
include alopecia and scalp disorders, cutaneous lymphocytic infiltrates,
and clinical-pathologic correlation of difficult inflammatory dermatoses.
Julie Reimann M.D., Ph.D. completed multiple fellowships at Harvard Medical
School/Brigham and Women’s Hospital, including dermatopathology
and soft tissue pathology, and she earned her M.D. and Ph. D. degrees
at Stanford University. Dr. Reimann’s areas of expertise include
melanoma and pigmented lesions, soft tissue tumors, epithelial neoplasms,
and alopecia, and she also has a particular interest in molecular dermatopathology.
She joins us from Virginia Mason Medical Center in Seattle.
Elsa Velazquez, M.D. will be joining us from her position as Assistant
Professor of Pathology at Harvard Medical School and Associate Dermatopathologist
at Brigham and Women’s Hospital. Dr. Velazquez completed her dermatopathology
fellowship and anatomic pathology residency at New York University Medical
Center. Dr. Velazquez has numerous peer-reviewed journal publications
and book chapters and presents frequently at national and international
conferences. Her interests include skin neoplasia, squamous cell carcinoma,
and malignant melanoma.
“Acquiring these distinguished pathologists furthers our commitment
to diagnostic excellence, research and education while broadening the
expertise and credentials of our already unprecedented team of diagnosticians,”
concluded Dr. Lash.
About Inform Diagnostics (formerly Caris Diagnostics)
Inform Diagnostics specializes in the development and commercialization
of the highest quality anatomic pathology services, primarily in the fields
of dermatopathology, Hematology/Oncology, gastrointestinal pathology and urologic
pathology. The company’s core team of more than 70 world-leading,
academic-caliber specialists utilize state of the art pathology laboratories
currently headquartered in Irving, TX and throughout the United States
to serve more than 3,000 patients every day. Through rigorous quality
assurance, daily and monthly conferences, and close relationships with
clinical partners, Inform Diagnostics continuously improves diagnostic